144 related articles for article (PubMed ID: 12549917)
21. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
22. DNA-looping by RXR tetramers permits transcriptional regulation "at a distance".
Yasmin R; Yeung KT; Chung RH; Gaczynska ME; Osmulski PA; Noy N
J Mol Biol; 2004 Oct; 343(2):327-38. PubMed ID: 15451664
[TBL] [Abstract][Full Text] [Related]
23. Activation of specific RXR heterodimers by an antagonist of RXR homodimers.
Lala DS; Mukherjee R; Schulman IG; Koch SS; Dardashti LJ; Nadzan AM; Croston GE; Evans RM; Heyman RA
Nature; 1996 Oct; 383(6599):450-3. PubMed ID: 8837780
[TBL] [Abstract][Full Text] [Related]
24. Synthetic retinoids dissociate coactivator binding from corepressor release.
Zechel C
J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
[TBL] [Abstract][Full Text] [Related]
25. Ligand-independent coregulator recruitment by the triply activatable OR1/retinoid X receptor-alpha nuclear receptor heterodimer.
Wiebel FF; Steffensen KR; Treuter E; Feltkamp D; Gustafsson JA
Mol Endocrinol; 1999 Jul; 13(7):1105-18. PubMed ID: 10406462
[TBL] [Abstract][Full Text] [Related]
26. Running increases neurogenesis without retinoic acid receptor activation in the adult mouse dentate gyrus.
Aberg E; Perlmann T; Olson L; Brené S
Hippocampus; 2008; 18(8):785-92. PubMed ID: 18493951
[TBL] [Abstract][Full Text] [Related]
27. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
28. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
[TBL] [Abstract][Full Text] [Related]
29. Corepressor recruitment by agonist-bound nuclear receptors.
White JH; Fernandes I; Mader S; Yang XJ
Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
[TBL] [Abstract][Full Text] [Related]
30. RAR antagonists diminish the level of DNA binding by the RAR/RXR heterodimer.
Poujol N; Margeat E; Baud S; Royer CA
Biochemistry; 2003 May; 42(17):4918-25. PubMed ID: 12718533
[TBL] [Abstract][Full Text] [Related]
31. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
[TBL] [Abstract][Full Text] [Related]
32. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
Bouton D; Escriva H; de Mendonça RL; Glineur C; Bertin B; Noël C; Robinson-Rechavi M; de Groot A; Cornette J; Laudet V; Pierce RJ
J Mol Endocrinol; 2005 Apr; 34(2):567-82. PubMed ID: 15821117
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner.
Pendaries V; Verrecchia F; Michel S; Mauviel A
Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262
[TBL] [Abstract][Full Text] [Related]
34. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
35. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding.
Figueira AC; Dias SM; Santos MA; Apriletti JW; Baxter JD; Webb P; Neves FA; Simeoni LA; Ribeiro RC; Polikarpov I
Cell Biochem Biophys; 2006; 44(3):453-62. PubMed ID: 16679533
[TBL] [Abstract][Full Text] [Related]
36. Ligand recognition by RAR and RXR receptors: binding and selectivity.
Sussman F; de Lera AR
J Med Chem; 2005 Oct; 48(20):6212-9. PubMed ID: 16190748
[TBL] [Abstract][Full Text] [Related]
37. Selective RXR modulators for the treatment of type II diabetes.
Faul MM; Grese TA
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
[TBL] [Abstract][Full Text] [Related]
38. Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1.
Morita K; Kawana K; Sodeyama M; Shimomura I; Kagechika H; Makishima M
Biochem Pharmacol; 2005 Dec; 71(1-2):98-107. PubMed ID: 16288995
[TBL] [Abstract][Full Text] [Related]
39. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
Ahuja HS; Szanto A; Nagy L; Davies PJ
J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Lefebvre P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]